ImmunoGen Inc. (NASDAQ: IMGN) reported second quarter 2020 earnings results today. Revenues were $15 million, compared to $15.5 million in the prior-year period. Net loss was $24.3 million, or $0.14 per share, compared to a loss of $43.4 million, or $0.29 per share, last year. For the full year of 2020, revenues are expected to be between $60-65 million. [irp posts=”59928″] ____
ImmunoGen Inc. (NASDAQ: IMGN) reported second quarter 2020 earnings results today. Revenues were $15 million, compared to $15.5 million in the prior-year period. Net loss was $24.3 million, or $0.14 per share, compared to a loss of $43.4 million, or $0.29 per share, last year. For the full year of 2020, revenues are expected to be between $60-65 million. [irp posts=”59928″] ____
ImmunoGen Inc. (NASDAQ: IMGN) reported second quarter 2020 earnings results today.
Revenues were $15 million, compared to $15.5 million in the prior-year period. Net loss was $24.3 million, or $0.14 per share, compared to a loss of $43.4 million, or $0.29 per share, last year.
For the full year of 2020, revenues are expected to be between $60-65 million.
[irp posts=”59928″]
____
